NECTIN4 and breast cancer: In addition, the knockdown of Nectin-4 by transfection of siRNA or the intravenous injections of anti-Nectin-4 monoclonal antibody inhibits tumor growth and reduces cell-cell contact in breast cancer cell lines in vivo [21].